Purpose of Review Viruses have vast diversity in terms of virion structure, genomic content, and host. All viruses, however, rely on host metabolism as none encode a metabolic network. Although virus-host metabolism interactions are critical to infection, little is understood regarding viral remodeling of its host metabolic network. Likewise, for most viruses, we have yet to identify if and how viruses govern the activity of metabolic pathways. Fortunately, metabolic analyses are becoming more accessible to virologist, thanks in large part to advances in mass spectrometry-based approaches. A brief overview of virus-metabolism interactions and the current state-of-the-art approaches to metabolomics, lipidomics and metabolic analyses are discussed. Recent Findings In the last several years, multiple metabolomic and lipidomic studies during virus infection have been reported. Products of the metabolic network support or limit infection. When considering how viruses interact with host metabolism it is critical for virologist to think beyond their copy of a Biochemistry textbook, as computational and analytical advances in recent years have led to novel discoveries in metabolism. Some of those advances and discoveries are introduced here, with a focus on the recent findings in virus-host metabolism interactions. Summary Metabolism is important to viral infections beyond simply keeping a cell alive while the virus replicates. Recent advances in tools and methods to dissect metabolism during infection have led to novel findings in infection-induced changes in metabolism. Continued research is necessary to build comprehensive understanding of how viruses interact with their host's metabolic network.
Introduction
Virus replication only occurs in host cells whose metabolism is permissive to infection. Minimally, replication requires the nucleotides, amino acids, and energy products produced by connected and highly coordinated metabolic pathways. Viruses do not encode a metabolic network within their genome, but some have the capacity to dramatically remodel their host's metabolism generating a "novel" network [1] [2] [3] [4] [5] [6] [7] . In addition to supporting virus replication, metabolism may be potentially antiviral, e.g., cyclic GMP-AMP (cGAMP) inducing STING-dependent antiviral responses [8] . The identification and characterization of cGAMP were done using metabolomics and proteomics. These omics, along with lipidomics, are rapidly advancing fields driven by computational and analytical advances, particularly in mass spectrometry. The rapid pace of novel discoveries in metabolism means that Biochemistry textbooks provide a broad simplification of metabolism and cannot keep pace with new findings. However, it is important to recognize our recent advances have only been made possible by the contribution of countless scientists that determined the reactions of metabolic networks without modern computers and scientific instruments.
As other global analyses, such as proteomics and RNAseq, are used to understand virus-host interactions, the need for virologists to rigorously perform metabolic investigations is likely to increase since some of these experiments will provide preliminary data suggesting a virus alters host metabolism [9••] . Metabolomic and lipidomic services are being offered by core facilities at many university and research institutes. Additionally, there are now several specialized companies providing these services as well. Subsequently, metabolomic and lipidomic analyses are more commonly being performed to understand infection. Therefore, virologists are now writing and/or being asked to review papers regarding viral control of host metabolism based on metabolomic datasets. Metabolomics and lipidomics have exciting potential for virologists to make important findings, but also pose multiple challenges.
Core metabolic pathways are well conserved, including the concentrations of metabolites and pathway control and regulation [10•] . For example, citrate is the same in bacteria, plants, and animals and has conserved functions in the tricarboxylic acid (TCA) cycle. This is advantageous to researchers since fundamental concepts and approaches to investigating metabolism are subsequently conserved, making metabolic studies in other fields-such as cancer-and virology mutually beneficial. Since several recent well-written reviews have discussed how various viruses alter metabolism [3, [11] [12] [13] [14] [15] [16] , this review will provide a virology-focused introduction to modern metabolomics and lipidomics approaches and recent advances in virus-host metabolism interactions.
Viruses Induce Diverse Metabolic Responses
The study of metabolism in virally infected cells has a long and rich history and contemporary research should be viewed as a revitalization in virus-host metabolism interactions. In the 1950s, a series of publications demonstrated that glucose, and likely an increase in glycolytically generated ATP, is required for polio virus replication [17, 18] . Shortly afterwards, it was found that the avian retrovirus, Rous sarcoma virus, increased the flow of carbons from glucose and acetate to lipids by 2-10-fold [19] . Venuta and Rubin, along with others, subsequently found that Rous sarcoma virus-infected cells had a higher rate of glucose import and glycolysis than uninfected avian cells [20, 21] . This Rous sarcoma virus work demonstrated that oncogenic viruses remodel host metabolism, fostering tumor growth. More recent work in metabolism of retroviruses focuses on lentiviruses. A comparison of HIV-1 and HIV-2 found that both alter the activity in glycolysis, TCA, and nucleotide metabolism [22] . Interestingly, only HIV-2 increases tryptophan catabolism in a Vpx-controlled manner. The authors suggest that metabolites in tryptophan degradation may increase the immune activation against HIV-2 and propose that metabolism is an important variable in lentivirus pathogenesis [22] .
Varying the nutrient conditions in cell culture growth medium demonstrated that glucose, galactose, and glutamine are important for HSV-1 replication [23] . Courtney et al. blocked HSV-1 replication using 2-deoxy-D-glucose to competitively inhibit glucose utilization [24] . Notably, 2-deoxy-D-glucose treatment similarly inhibits the replication of influenza virus [25] , Semliki Forest virus [26] , and Rous sarcoma virus [27] .
These early works showed that unrelated viruses require the same metabolic pathway.
More recently, HSV-1 was found to use glucose for pyrimidine synthesis via anaplerotic feeding into the TCA cycle (i.e., converting pyruvate into the TCA intermediate oxaloacetate, instead of acetyl-CoA) [2, 28] . However, related human herpesviruses have divergent effects on metabolism: human cytomegalovirus (HCMV) has no effect on pyruvate conversion to oxaloacetate [1-4, 29-31, 32, 33, 34••, 35] . Further, HSV-1 has little effect on glucose import [2] while HCMV, Epstein-Barr virus (EBV), and Kaposi's sarcoma herpesvirus (KSHV) increase glucose uptake and alter glucose transporter expression [2, 31, [36] [37] [38] . Like herpesviruses, not all flaviviruses are metabolically alike. Infection with dengue virus (DENV) and West Nile virus (WNV) increases ceramide lipid levels [39, 40] . However, a depletion of ceramides prior to infection suppresses WNV replication while enhancing DENV replication [41] demonstrating that the role of ceramides during infection is divergent. Other viruses exert their own specific control over host metabolism (e.g., flaviviruses [15, 42, 43, 44 •], adenoviruses [45] , pox viruses [5, 46, 47] ).
Since unrelated viruses depend on similar pathways while related viruses remodel metabolism divergently, it is difficult to predict metabolic phenotypes of infected cells. Results from the last 70 years show that each virus creates a unique metabolic phenotype, highlighting the need to continue investigating infection from the perspective of metabolism.
Introduction to Fundamentals of Metabolism

Metabolism: Beyond Metabolomics and Lipidomics
In this review, we are using this "functional" definition of metabolism: a life-sustaining process that prevents an organism from reaching equilibrium with its environment. A metabolic network involves connecting 100s to 1000s of chemical reactions carried out by enzymes. Not only are these reactions required for a cell to live, but they also give rise to the cell's phenotype. Metabolomics and lipidomics provide measurements of the abundance of metabolites and lipids. Although these omics measurements are a helpful first step in determining if and how infection may alter metabolism, they only provide a partial understanding of metabolic activity. Since a single change in abundance can be due to multiple factorse.g., an increase in abundance can be due to a stimulation in synthesis or a suppression of degradation-comprehensive understanding of metabolism requires determining abundances and enzymatic activities. Flux analyses, kinetic isotope tracing, and enzyme assays can provide direct measurement of enzyme activity.
Two methods are commonly used to determine flux rates: flux balance analysis and kinetic flux profiling. Flux balance analysis examines the uptake and secretion rates of a pathway, while kinetic flux profiling uses metabolic tracers and metabolite concentrations [10•, 48-50] . Munger et al. used kinetic flux profiling using 13C-glucose as a tracer to determine that HCMV upregulates central carbon metabolism, particularly the flow of carbons from glucose to fatty acid metabolism [1] . This work provided an in-depth understanding of HCMV-induced changes to metabolic activity and demonstrates that understanding metabolism goes beyond metabolomics. An alternative to determining flux values, virologist can determine how viruses alter the activity in a pathway by using isotopic tracers to measure relative fractional labeling [2, 51, 52•] . In this case, the fractional labeling for each metabolite is determined by measuring the amount of the labeled form relative to the total (i.e., labeled + unlabeled). If infected cells label a metabolite faster than uninfected control cells, then it can be concluded the virus increases the synthesis rate for that metabolite. Determining how viruses alter metabolic activity provides a more complete understanding of the virus-host metabolism interaction than can be discovered by only metabolomics or lipidomics.
Metabolic Control and Regulation
A metabolic network consists of coordinated metabolic pathways. The activity of each enzyme and pathway help provide the overall phenotype of the network. Thus, the control and regulation of the individual enzymes in the pathway are critical to the overall biology of a cell. Metabolic control involves flux alterations due to a change in conditions, such as infection, whereas metabolic regulation maintains homeostatic concentrations of individual metabolites that may otherwise dramatically change when flux is altered. Rather than conceptualizing the control and regulation of an entire metabolic network, a simpler approach is to think in terms of an individual metabolite (i.e., substrate) reaching a functional enzyme (i.e., active site). An increase in the concentration of a metabolite and active site will result in an increase in metabolic activity. In contrasts, a decrease in a metabolite or active site abundance will result in a lessening of metabolic activity.
Control of Functional Active Site
The level of functional active sites can be regulated by cells via multiple mechanisms. The balance of enzyme synthesis and degradation can directly influence active site available for metabolic reactions. Some viruses use transcription factors to tip the balance in favor of increased active sties, and thus metabolic activity. Viruses do this most notably in lipid metabolism [52•, 53, 54, 55, 56] . Replication of diverse viruses, such as HCMV [52•, 53, 54] and Andes virus [55] , relies on sterol regulatory element-binding proteins (SREBPs) to transcriptionally upregulate enzymes in lipid synthesis. Viruses may also encode factors that mimic hormones and growth factors that could regulate metabolism. A bioinformatic search led to the discovery that iridoviruses encode insulinlike peptides capable of stimulating signaling in mammalian cells [57] , which could possibly lead to transcriptional control of over 100 genes [58] . In contrast to the balance shifting towards increased synthesis of enzymes, HSV-1 controls metabolism by targeting at least one enzyme for depletion [28] .
Functional active sites can also be altered by mechanisms that are independent of protein abundance. The activity of some metabolic enzymes is controlled by post-translational modifications or structure (e.g., dimerization). Since metabolic activity is compartmentalized in a cell (e.g., mitochondrial versus cytosolic), subcellular localization of enzymes can control its function. For example, tomato bushy stunt virus RNA synthesis involves relocating pyruvate kinase to replication complexes [59] . DENV takes advantage of this strategy as well by moving fatty acid synthase from the cytosol to viral replication sites [42] .
Unlike DENV, other viruses stimulate fatty acid synthesis and elongation by regulating the enzyme catalyzing the first-committed step of the pathway, acetyl-CoA carboxylase-1 (ACC1). ACC1 adds a carbon to acetyl-CoA to generate malonyl-CoA. The malonyl-CoA product is the substrate for fatty acid synthase and fatty acid elongases. ACC1 is regulated via multiple mechanisms [60] . ACC1 is transcriptionally controlled by SREBPs. The enzymatic activity of ACC1 is post-transcriptionally controlled by phosphorylation. In low energy states, AMPK phosphorylates ACC1 blocking its dimerization, preventing its activity [61] . AMPK or ACC1 is important to the infection of flaviviruses [44•, 62, 63] . HCMV infection also activates AMPK [64, 65] , increasing glycolysis and the phosphorylated form of ACC1 [64] . This would typically suppress fatty acid synthesis and elongation; however, HCMV replication requires these processes [1, 51, 52•, 53] . To maximize the benefits of AMPK activation to replication and minimizing it detriment to infection, HCMV takes advantage of the multiple mechanisms governing ACC1 activity. HCMV increases the overall levels of ACC1 by enhancing its SREBP-dependent transcription [53] . In addition to increasing ACC1 protein levels, HCMV induces the activity of ACC1 through mechanisms that are not fully understood [53] . In contrast to HCMV, an AMPK-mediated response restricts Rift Valley fever virus infection [66] , but it is unknown if this involves ACC1.
Control of Substrate
Most metabolic reactions may likely be controlled by substrate availability [67••] . Work from model systems suggests that functional active sites are in abundance, while the substrates tend to be the limiting factor [67••, 68] . This suggests that for many metabolic steps, transcript or protein levels will poorly correlate with metabolic activity. Since these studies focused on water-soluble metabolites, it is unknown if this also applies to lipid metabolism. Rate-limiting or pathwaydetermining steps may be controlled by one or more allosteric regulators. Importantly, new points of regulation in metabolism are being defined as analytical and computational methods to measure metabolites and metabolic fluxes improve [67••, 69] . For example, HSV-1 viral genome replication can be limited by directing aspartate from pyrimidine nucleotide synthesis towards arginine synthesis via the action of argininosuccinate synthetase-1 [28] . In this case, the metabolite substrate for a certain pathway can be regulated by competing pathways, effectively decreasing the concentration of the substrate pyrimidine synthesis enzymes. Subsequently, HSV-1 downregulates argininosuccinate synthetase-1 to minimize its antiviral effects [28] .
Metabolomics and Lipidomics: Approaches
Instrumentation
Metabolites and lipids can be identified and quantitatively measured by targeted and untargeted approaches. Mass spectrometry (MS) and nuclear magnetic resonance (NMR) can be used for metabolomics or lipidomics. In addition to quantitative information, NMR can also provide structural information on metabolites. NMR in comparison to MS has low sensitivity which limits measuring less abundant metabolites. However, NMR is the preferred method for metabolites that do no form ions, since MS requires ionization. Most MS instruments are sensitive enough to quantitatively measure compounds over a broader range of concentrations (e.g., nanomolar to millimolar range when samples are properly prepared). MS techniques allow for the greatest coverage of the metabolome or lipidome, with reasonable throughput (typically 20-45 min per sample). Metabolomic and lipidomic approaches using MS will be the focus of the rest of this review.
Targeted and Untargeted MS Approaches
Targeted MS involves examining a predetermined list of metabolites or lipids. In this case, the MS instrumentation is tuned to identify and measure only "known" metabolites or lipids. Targeted approaches can identify 10s-100s of metabolites and lipids. Targeted metabolite and lipid analysis commonly use triple-quad instruments. Well-developed methods and analytical tools for quantitative targeted metabolite and lipid identification are widely available [70, 71••] , decreasing the experimental thresholds and costs for data generation.
Traditionally, most metabolic experiments have been targeted analyses. However, improvements in instrumentation, costs, and bioinformatics tools are allowing more scientists to use untargeted approaches. Untargeted approaches involve attempting to record all ionizable metabolites or lipids within a defined mass range. In this case, recorded mass spectral features represent "unknown" compounds that are identified following data collection. Mass spectrometers used for untargeted analyses must have the ability to collect full-scan high-resolution data. As these instruments-typically a qTOF, oribitrap, or FTICR-become more common, the threshold to generating untargeted datasets is decreasing. A single experiment may have well over 20,000 individual mass spectral peaks, creating a significant post data collection barrier. Determining peaks of interest, assigning initial identification, and confirmation of identification are computationally intensive and time consuming. Additionally, a single metabolite or lipid may generate multiple "unknown" peaks due to adduct formation or fragmentation [71••, 72] . However, untargeted approaches can generate new discoveries, e.g., identification of an oncometabolite [73] . As the field continues to evolve, a hybrid approach is emerging: data collected using untargeted approaches are analyzed in a targeted fashion. Identified peaks that were unknown are added to a library of knowns following confirmation of their identity, allowing for quick analysis of part of the dataset.
Metabolites and lipids are structurally and chemically diverse, so it is unsurprising that the greatest data will be achieved when a single sample is examined using multiple different approaches (Fig. 1) . Samples can be extracted using various methods (e.g., hydrophilic vs. hydrophobic) and separated via different modes, as discussed later. Similarly, there are several MS/MS data collection options (e.g., negative and positive ion modes, higher energy collisional dissociation, electron-induced dissociation, UV-photodissociation) [71••, 74-76] . For metabolomics and lipidomics, one must be comfortable-but not satisfiedin developing methods that are well-suited for examining the most metabolites or lipids possible. The limitation of such an approach is that the best method for analyzing any given metabolite or lipid is forfeited.
Given the complexity of metabolites and lipids in samples from biological origin, the separation of compounds prior to MS analysis is required to increase overall coverage of the metabolome or lipidome. Typically, ultra-high-pressure liquid chromatography (UHLPC) or gas chromatography (GC) is performed in-line with MS. Instruments capable of ion mobility (IM) can separate compounds based on structural differences following ionization. These instruments are now commercially available. During IM, ions interact with a drift gas that enables separation based on structure [77, 78] . As IM techniques, software, and databases for metabolites and lipids are further developed, its possible benefits to metabolomics and lipidomics will become more clear. IM can be coupled to UHLPC and GC. Together, these approaches allow for multiple dimensions to metabolite identification and quantification, e.g., UHLPC retention time, IM "drift time," and highresolution parent ion and fragment ion information [77, 79] . Importantly, these techniques separate compounds based on the chemical and/or structural nature of metabolites and lipids. This provides multiple benefits as highlighted in the next section.
Challenges in Performing and Interpreting Metabolic Experiments
Metabolites and lipids are elementally simple, as most are composed of carbon (C), hydrogen (H), oxygen (O), nitrogen (N), phosphorus (P), and sulfur (S) atoms. However, they are structurally and chemically diverse. For example, choline (C 5 H 14 NO) is a small (104.108 exact mass), water-soluble metabolite that is a precursor for acetylcholine (a neurotransmitter), betaine (important for one-carbon metabolism), and phosphatidylcholine lipids (PCs). In contrast to choline, PCs are hydrophobic lipids that are important for biological membranes. There are over 1000 possible PC lipids listed in the LIPIDMAPS database. Typically, they have ≥ 32 C, ≥ 60 H, a single N and P, and 8 O atoms. Identifying and quantifying such a large chemical space in samples from biological sources are challenging. Metabolite specific methods are typically limited in their ability to examine lipid species, and vice versa. Furthermore, optimized methods for a class of metabolites are often poor for other classes. Fortunately, as access to new methods and instrumentation increases so are the studies that integrate multiple approaches [9••, 80] .
Metabolomics and lipidomics, unlike proteomics, have no universally accepted mechanism to define false positive discovery rates. It is still too early to know how the widespread usage of new software tools will impact misidentification of metabolites and lipids. For confidence in reporting, researchers must-whenever possible-use standards to determine analyte properties such as chromatographic retention times, IM drift times, and MS/MS fragments (Fig. 1) . If possible, isotopic labeling the metabolic pathway also provides confidence in identification. Standards for most metabolites can easily be purchased from multiple vendors. Given the large diversity in lipids, standards for most lipid species in a class are unavailable. In this case, care should be taken to use available lipids standards as representative of the lipid class.
Metabolites and lipids can have vastly different concentrations, ranging from nanomolar to millimolar levels. LC-MS/ MS is sensitive and has a large dynamic range, allowing for quantification of low and high abundant metabolites and lipids. However, under certain circumstances, MS detection of metabolites and lipids may fall outside of the linear range where the MS signal is proportional to the analyte concentration. For example, a loss of ionization may occur if highly abundant metabolites prevent the ionization of other metabolites resulting in a loss in signal (i.e., ion suppression).
Some metabolites and lipids are isomers (e.g., citrate and isocitrate, leucine and isoleucine, ATP and dGTP). Since these compounds have the same mass, they must be chromatographically separated by another method like UHPCL or IM. Some metabolites are unstable, resulting in their loss or transformation during extraction, LC/GC separation, or ionization. Metabolite and lipid degradation and interconversion can lead to errors in both identification and quantification. This is Metabolites and lipids can be fragments via multiple methods as discussed in the text. Following data acquisition, sample-dependent mass spectral features (i.e., peaks) must be found and background ions must be excluded. Peaks of biological interest can be further characterized, and their identity confirms using commercially available standards when available. Finally, for a comprehensive understanding of virus-host metabolism interactions then the metabolomics or lipidomics observations should be used to guide further experiments to investigate metabolic activity. These can include determining metabolic activity using isotopic tracers or knocking out host enzymes to test their role in infection and viral-induced metabolic remodeling particularly troublesome, if a metabolite is ex vivo altered to become another metabolite. For example, ATP hydrolysis can generate ADP or AMP leading to potential misinterpretation concerning the energy status of the cell [71••, 72] . Those considering developing their own approaches-or wanting to evaluate others' approaches-will find a recent review that carefully outlined the experiences from the laboratories of Oliver Fiehn and Joshua Rabinowitz in establishing metabolomics approaches helpful [71••] .
Conclusions
Metabolism and Pathogenesis: Building Virions and Beyond
All viruses rely on host metabolism to provide the energy and materials-e.g., nucleotides, amino acids, or lipids-required for virus replication. This requirement is important in itself [3, 5, 11, 15, 28-31, 33, 43, 44•, 46, 51, 52•, 54, 81, 82] ; however, infection alters host metabolism in ways that likely go beyond those required to build a virion [83, 84] . Chronic hepatitis B virus infection alters serum metabolites and lipids, potentially reflecting liver damage rather than metabolic needs for viral replication [83] . Similarly, DENV leads to shifts in serum metabolites [84, 85] . Further, metabolism is now recognized as a significant factor determining immune outcomes (as reviewed in [86, 87] ). Viruses may potentially take advantage of metabolism to alter an immune response to evade clearance. Alternatively, infection could trigger metabolic responses that stimulate immune or other antiviral control measures. So far, this area has received little research attention.
Untargeted metabolomics and lipidomics provide advantages to determining how metabolism participates in viral pathogenesis. Untargeted metabolomics may identify a metabolite or metabolic pathway affected by viral infection that was previously not hypothesized to be important. This is a more likely outcome than discovering new metabolites or pathways. In contrasts, an extensive lipidomic study suggests that only 50% of the > 5000 lipids in the human platelet lipidome have been identified [75] . This observation suggests that untargeted lipidomics has the potential for novel discoveries. Since the pathogenesis of some viruses relies on lipid metabolism, untargeted lipidomics of infected cells may likely lead to the identification of many previously undescribed lipid species. This line of investigation could have significant impact in furthering our understanding of how viruses interact with their hosts and in understanding lipid metabolism in general.
Mechanisms of Viral Metabolic Hijacking
In addition to identifying virally induced changes in metabolites and lipids, research must be done to define the viral and host mechanisms that drive metabolism to play a supportive or detrimental role in infection. Viruses can remodel metabolism by directly targeting metabolic enzymes, signaling pathways, transcription factors, or organelles with important metabolic functions. Hepatitis C virus (HCV) NS5A targets hexose kinase to increase glycolysis [88] . HCMV pUL38 increases the expression of fatty acid elongase 7 in an mTOR-and SREBP1-dependent pathway [52•] . In the nucleus of epithelial cells, adenovirus E4 Orf1 uses Myc to induce glycolytic genes in a way that is striking enough to change the tissue culture medium from red to deep yellow in color [45] . Many viruses encode proteins or non-coding RNAs that target mitochondria [89] [90] [91] [92] . When expressed without infection, KSHV microRNAs reduced the number of mitochondria causing the cell to switch from ATP production via oxidative phosphorylation to glucose conversion to lactate [93] . HCMV encodes a protein (pUL37) [94] and non-coding RNA (β2.7) [95] that target mitochondria; however, any possible metabolic function of these factors has yet to be described. In addition to metabolism, mitochondria are also essential sites for apoptosis and mitochondrial antiviralsignaling (MAVS) proteins [96] , making them important sites for pathogenesis. It is unclear if metabolism, apoptosis, and MAVS signaling influence each other during infection. On the host side, a few central players have emerged including AMPK [64, 65] and mTOR [11, 34••, 38, 44•, 52•, 53, 97] . Many of these pathways are also known to alter central carbon and amino acid metabolism in cancers [98, 99] . Other processes related to cell growth or oncogenic regulation of metabolism are likely to be targeted by viruses, including HIF1α as was demonstrated in HCV infection [93, 100] .
Future opportunities to use metabolomics and lipidomics will lead to novel discoveries in virus biology and have the potential to identify antiviral targets. Stimulated by access to modern approaches to globally analyze metabolism, researchers are now building better understandings of how viruses interact with their host's metabolic network. With this increase in access, it will be important that metabolomics and lipidomics data is rigorously interpreted, especially when using untargeted approaches. Metabolomic and lipidomics analyses are descriptive. Any omics dataset should be coupled with research defining metabolic activity (e.g., flux analyses, enzymatic inhibitors or activators, or activity ablation or activation using genetics) to be fully informative. Defining the multiple mechanisms and molecular players-both viral and cellular-required for viral remodeling of metabolism will have great value in basic biology and perhaps one day in the clinic as well.
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